AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Adenocarcinoma of the Colon

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps NCT05080673NA493 sites๐Ÿ“ Fairbanks๐Ÿ“ Goodyear๐Ÿ“ Kingman NRG Oncology ยท Tests: 5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3 NCT07595874Phase 211 sites๐Ÿ“ Goodyear๐Ÿ“ Corona๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Balstilimab, Biospecimen Collection, Botensilimab, Computed Tomography, Magnetic Resonance Imaging A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Shanghai GV20 Therapeutics ยท Tests: GV20-0251 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631Phase 19 sites๐Ÿ“ Princeton๐Ÿ“ Montreal๐Ÿ“ Odense C Novartis Pharmaceuticals ยท Tests: 68Ga-NNS309, 177Lu-DFC413 BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079Phase 117 sites๐Ÿ“ Los Angeles๐Ÿ“ Sacramento๐Ÿ“ San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) ยท Tests: BBO-11818, Pembrolizumab, Platinum chemotherapy (cisplatin or carboplatin), Pemetrexed, Cetuximab THE-0504 in Patients With Solid Tumors NCT07646106Phase 11 site๐Ÿ“ Rome Thena Biotech S.r.l. ยท Tests: THE-0504 PRE-ISPY Phase I/II Oncology Platform Program NCT05868226Phase 1, Phase 210 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Aurora QuantumLeap Healthcare Collaborative ยท Tests: ALX148, Fam-Trastuzumab Deruxtecan-Nxki, Zanidatamab, Tucatinib, TTX-MC138 BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours NCT04421820Phase 1, Phase 228 sites๐Ÿ“ Santa Monica๐Ÿ“ Tampa๐Ÿ“ Edmonton Bold Therapeutics, Inc. ยท Tests: BOLD-100 ยฑ FOLFOX ยฑ Bevacizumab Chemotherapy (Arm VII), BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI) A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites๐Ÿ“ Los Angeles๐Ÿ“ Denver๐Ÿ“ New Haven GV20 Therapeutics ยท Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDAยฎ], GV20-0251 and Pembrolizumab [KEYTRUDAยฎ] A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site๐Ÿ“ Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-8989 The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors NCT04624555n/a1 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial NCT05673148Phase 2189 sites๐Ÿ“ Kingman๐Ÿ“ Phoenix๐Ÿ“ Beverly Hills Alliance for Clinical Trials in Oncology ยท Tests: Stereotactic Ablative Radiotherapy, Resection, Microwave Ablation, Chemotherapy, Computed Tomography Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection NCT06703632NA2 sites๐Ÿ“ Lisbon๐Ÿ“ Madrid ADVANCED MARKER DISCOVERY S.L. ยท Tests: blood sampling, Survey using a questionnaire., Survey using a questionnaire. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors NCT06983743Phase 19 sites๐Ÿ“ Santa Rosa๐Ÿ“ Aurora๐Ÿ“ Sarasota Erasca, Inc. ยท Tests: ERAS-0015, ERAS-0015 in combination DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites๐Ÿ“ Belfast๐Ÿ“ Birmingham๐Ÿ“ Birmingham Cancer Research UK ยท Tests: Dabrafenib, Trametinib Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation NCT05288205Phase 1, Phase 227 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Beijing Allist Pharmaceuticals, Inc. ยท Tests: JAB-21822, JAB-3312 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors NCT06218914Phase 118 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Newport Beach AstraZeneca ยท Tests: NT-112: Autologous, engineered T Cells targeting KRAS G12D, AZD0240: Autologous, engineered T Cells targeting KRAS G12D HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer NCT06709885Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Chidamide + Tislelizumab + chemotherapy (CapeOX ), CapeOX A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites๐Ÿ“ Denver๐Ÿ“ Orlando๐Ÿ“ Detroit BioNTech SE ยท Tests: BNT329, CA19-9-targeting monoclonal antibody A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression NCT06682793Phase 1, Phase 210 sites๐Ÿ“ Gilbert๐Ÿ“ La Jolla๐Ÿ“ Los Angeles A2 Biotherapeutics Inc. ยท Tests: A2B395, xT CDx with HLA-LOH assay Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440n/a6 sites๐Ÿ“ Monrovia๐Ÿ“ San Diego๐Ÿ“ Dalian City of Hope Medical Center ยท Tests: DENEB A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Little Rock Artios Pharma Ltd ยท Tests: ART0380, Gemcitabine, Irinotecan A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors NCT06508307Phase 11 site๐Ÿ“ Zhengzhou GONGCHU Biotechnology Co., Ltd ยท Tests: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT07435038Phase 1, Phase 27 sites๐Ÿ“ Blacktown๐Ÿ“ Randwick๐Ÿ“ Sydney Betta Pharmaceuticals Co., Ltd. ยท Tests: BPI-572270 Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors NCT07630961Phase 12 sites๐Ÿ“ Odense C๐Ÿ“ Chuo Ku Novartis Pharmaceuticals ยท Tests: 68Ga-DFC413, 68Ga-NNS309
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy